Crisaborole (CAS 906673-24-3) is a boron-containing topical drug used for the treatment of mild to moderate atopic dermatitis. It inhibits phosphodiesterase-4 (PDE4), reducing inflammation and itching.
Crisaborole
Category:Organic Intermediates
CAS No.:906673-24-3
Product Grade: Pharma grade
Purity / Assay: 99%
Molecular Formula:C₁₄H₁₀BNO₃
Molecular Weight:251.05
EINECS No.:250-635-4 (696-120-1)
Synonym(s):Crisaborole; AN2728; 4-[(1-Hydroxy-1,3-dihydro-2,1-benzoxaborol-5-yl)oxy]benzonitrile
Crisaborole (CAS 906673-24-3) is a boron-containing topical drug used for the treatment of mild to moderate atopic dermatitis. It inhibits phosphodiesterase-4 (PDE4), reducing inflammation and itching.
1. Active pharmaceutical ingredient for mild to moderate atopic dermatitis. 2. PDE4 inhibitor for inflammatory skin disease research. 3. Boron-containing pharmaceutical intermediate for medicinal chemistry. 4. Dermatology and topical drug-delivery research.
25kg/drum; 200kg/drum
CAS No.: 906673-24-3
Product Name: Crisaborole
Purity / Assay:99%
Molecular Formula:C₁₄H₁₀BNO₃
Molecular Weight:251.05
EINECS No.:250-635-4 (696-120-1)
Synonym(s):Crisaborole; AN2728; 4-[(1-Hydroxy-1,3-dihydro-2,1-benzoxaborol-5-yl)oxy]benzonitrile
For global customers, we provide complete technical documentation to support product evaluation, regulatory compliance and safe handling during transportation and application.